Davison J, Degner LF, Morgan TR. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 1995; 22: 1401–1408.
Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE. Cancer patients: Their desire for information and participation in treatment decisions. J Royal Soc Med 1989; 82: 260–263.
Wiggers JH, Donovan KO, Redman S, Sanson-Fisher RW. Cancer patient satisfaction with care. Cancer 1990; 66: 610–616
Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980; 92: 832–836.
Chaitchik S, Kreitler S, Shaked S, Schwartz I, Rosin R. Doctor-patient communication in a cancer ward. J Cancer Educ 1992; 7: 41–54.
Feldman-Stewart D, Brundage MD, Hayter C, et al. What questions do patients with curable prostate cancer want answered? Med Decision Making 2000; 20: 7–19.
Bezjak A, Taylor KM, Ng P, Macdonald K, DePetrillo AD. Quality-of-life information and clinical practice: The oncologist's perspective. Cancer Prevent Control 1998; 2: 230–235.
Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care. Ann Intern Med 1985; 102: 520–528.
Jacobs C, Ross RD, Walker IM, Stockdale FE. Behavior of cancer patients: A randomized study of the effects of education and peer support groups. Am J Clin Oncol (CCT) 1983; 6: 347–350.
Meyerowitz BE, Watkins IK, Sparks FC. Psychosocial implications of adjuvant chemotherapy. Cancer 1983; 52: 1541–1545.
Molleman E, Krabbendam PJ, Annyas AA, Kloops HS, Sleijfer DT, Vermey A. The significance of the doctor-patient relationship in coping with cancer. Social Sci Med 1984; 18: 475–480.
Wallace LM. Informed consent to elective surgery: The 'therapeutic' value? Social Sci Med 1986; 22: 29–33.
Aaronson NK, Ahmedzai S, Bergman B. The European Organization for Research and Treatment of Cancer QLQC30: A quality-of-life instrument for use in international clinical trials in Oncology. J Nat Cancer Inst 1993; 85: 365–376
de Haes JC, van Knippenberg FC. Quality of life instruments for cancer patients: 'Babel's Tower revisited'. J Clin Epidemiol 1989; 42: 1239–1241.
Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: A multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 1997; 11: 3–20.
Cohen SR, Mount BM, Tomas JJ, Mount LF. Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer 1996; 77: 576–586.
Till JE. Measuring quality of life: Apparent benefits, potential concerns. Can J Oncol 1994; 4: 243–248.
Browman GP. Science, language, intuition, and the many meanings of quality of life. J Clin Oncol 1999; 17: 1651–1653.
Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272: 619–626.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–629.
Neymark N, Kiebert W, Torfs K, et al. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop. Eur J Cancer 1998; 34: 1317–1333.
Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res 1993; 2: 369–395.
Till JE, Osoba D, Pater JL, Young JR. Research on health-related quality of life: Dissemination into practical applications. Qual Life Res 1994; 3: 279–283.
Kiebert G, Wait S, Bernhard J, et al. Practice and policy of measuring quality of life and health economics in cancer clinical trials: A survey among co-operative trial groups. Qual Life Res 2000; 9: 1073–1080.
Osoba D, Dancey J, Zee B, Myles J, Pater J. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group. J Nat Cancer Institute 1996; Monographs: 107–111.
Ashbury FD, Lockyer L, McKerracher K, Findlay H. Focus groups with cancer patients: Toward a more comprehensive understanding of the cancer experience. Cancer Prevent Control 1997; 1: 222–227.
Degner LF, Sloan JA. The control preferences scale. Can J Nurs Res 1997; 29: 21–43.
Feldman-Stewart D, Brundage MD, Nickel JC, Mackillop WJ. The information required by patients with early-stage prostate cancer in choosing their treatment. Brit J Urol Internat 2001; 87: 218–223.
Asbury J. Overview of focus group research. Qual Health Res 1995; 5: 414–420.
Morgan DL. Focus groups as qualitative research. Newbury Park, CA: Sage, 1988.
Krueger RA. Focus Groups: A Practical Guide for Applied Research, 2nd ed. Newbury Park, CA: Sage Publications, 1994.
Greenbaum ER. The Handbook for Focus Group Research, 2nd ed. Thousand Oaks, CA: Sage Publications, 1998.
Carey MA. Comment: Concerns in the analysis of focus group data. Qual Health Res 1995; 5: 487–495.
Carey MA, Smith MW. Capturing the group effect in focus groups: A special concern in analysis. Qual Health Res 1994; 4: 123–127.
Cleveland WS, McGill R. Graphical perception: Theory, experimentation, and application to the development of graphical methods. J Am Statist Assoc 1984; 79: 531–554.
Cleveland WS, McGill R. Graphical perception and graphical methods for analyzing scientific data. Science 1985; 229: 828–833.
Feldman-Stewart D, Kocovski N, McConnell B, Brundage M, Mackillop W. Perception of quantitative information for treatment decisions. Med Decision Making 2000; 20: 228–238.
Elting LS, Martin CG, Cantor SB, Rubenstein EB. Influence of data display formats on physician investigators' decisions to stop clinical trials: Prospective trial with repeated measures. Brit Med J 1999; 318: 1527–1531.
Ottenbacher KJ. When is a picture worth a thousand p values? A comparison of visual and quantitative methods to analyze single subject data. J Special Educ 1990; 23: 436–449.
Carswell CM. The art and psychological science of graphical communication. Psychol Sci Agenda 1995; 8–9.
Mazur DJ, Hickam DH. Interpretation of graphic data by patients in a general medicine clinic. J Gen Intern Med 1990; 5: 402–405.
Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J 1998; 316: 690–693.